The Future of Precision Medicine is Radiopharmaceuticals
Here’s why so many people in the industry are excited about the potential of radiopharmaceuticals for diagnosis and treatment.
-
1
Radiopharmaceuticals combine radioisotopes with biological molecules for targeted diagnostic and therapeutic applications.
-
2
The global market for radiopharmaceuticals is projected to grow from $7.9 billion in 2023 to $21.8 billion by 2033.
-
3
Lutetium-177 is the most widely used therapeutic isotope, effectively targeting cancer cells while minimizing damage to healthy tissue.
-
4
Clinical trials show significant improvements in disease progression and survival rates for patients treated with radiopharmaceuticals.
-
5
Access to radiopharmaceuticals is challenged by supply chain issues, workforce shortages, and inequities between high- and low-income countries.
